Bio-Path Holdings, Inc. (BPTH)
0.0005
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Bio-Path Holdings EPS Diluted (Quarterly) : -0.0875 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0875 |
| March 31, 2026 | -0.0289 |
| December 31, 2025 | -0.0269 |
| September 30, 2025 | -0.1145 |
| June 30, 2025 | -0.5533 |
| March 31, 2025 | -0.4038 |
| December 31, 2024 | -0.4773 |
| September 30, 2024 | -0.701 |
| June 30, 2024 | -1.159 |
| March 31, 2024 | -4.879 |
| December 31, 2023 | -5.456 |
| September 30, 2023 | -6.364 |
| June 30, 2023 | -10.64 |
| March 31, 2023 | -13.25 |
| December 31, 2022 | -11.08 |
| September 30, 2022 | -9.874 |
| June 30, 2022 | -8.402 |
| March 31, 2022 | -9.383 |
| December 31, 2021 | -11.50 |
| September 30, 2021 | -5.880 |
| June 30, 2021 | -5.195 |
| March 31, 2021 | -8.554 |
| December 31, 2020 | -11.44 |
| September 30, 2020 | -16.08 |
| June 30, 2020 | -11.05 |
| Date | Value |
|---|---|
| March 31, 2020 | -18.01 |
| December 31, 2019 | -14.46 |
| September 30, 2019 | -15.61 |
| June 30, 2019 | -17.37 |
| March 31, 2019 | -17.79 |
| December 31, 2018 | -56.14 |
| September 30, 2018 | -107.46 |
| June 30, 2018 | -59.15 |
| March 31, 2018 | -67.58 |
| December 31, 2017 | -80.00 |
| September 30, 2017 | -80.00 |
| June 30, 2017 | -120.00 |
| March 31, 2017 | -16.60 |
| December 31, 2016 | -40.00 |
| September 30, 2016 | -80.00 |
| June 30, 2016 | -80.00 |
| March 31, 2016 | -80.00 |
| December 31, 2015 | -80.00 |
| September 30, 2015 | -80.00 |
| June 30, 2015 | -40.00 |
| March 31, 2015 | -80.00 |
| December 31, 2014 | -80.00 |
| September 30, 2014 | -40.00 |
| June 30, 2014 | -40.00 |
| March 31, 2014 | -40.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Yulong Eco-Materials Ltd. | -0.0047 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.636M |
| Total Expenses (Quarterly) | 2.636M |
| Enterprise Value | 0.5441M |
| Earnings Yield | -51.56K% |
| Normalized Earnings Yield | -36160.00 |